Compare SUVEN LIFE with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES IPCA LABS SUVEN LIFESCIENCES/
IPCA LABS
 
P/E (TTM) x 19.5 22.9 84.8% View Chart
P/BV x 3.9 4.4 88.6% View Chart
Dividend Yield % 0.5 0.1 506.8%  

Financials

 SUVEN LIFESCIENCES   IPCA LABS
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
IPCA LABS
Mar-18
SUVEN LIFESCIENCES/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs338695 48.6%   
Low Rs169400 42.4%   
Sales per share (Unadj.) Rs52.1260.2 20.0%  
Earnings per share (Unadj.) Rs6.819.0 36.0%  
Cash flow per share (Unadj.) Rs8.633.1 25.9%  
Dividends per share (Unadj.) Rs1.501.00 150.0%  
Dividend yield (eoy) %0.60.2 324.0%  
Book value per share (Unadj.) Rs65.3213.0 30.6%  
Shares outstanding (eoy) m127.28126.20 100.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.92.1 231.1%   
Avg P/E ratio x37.128.9 128.6%  
P/CF ratio (eoy) x29.616.6 178.6%  
Price / Book Value ratio x3.92.6 151.1%  
Dividend payout %22.05.3 416.6%   
Avg Mkt Cap Rs m32,27269,120 46.7%   
No. of employees `0001.113.3 8.2%   
Total wages/salary Rs m6617,359 9.0%   
Avg. sales/employee Rs Th6,132.22,477.4 247.5%   
Avg. wages/employee Rs Th611.1555.2 110.1%   
Avg. net profit/employee Rs Th803.5180.6 444.8%   
INCOME DATA
Net Sales Rs m6,63532,836 20.2%  
Other income Rs m242418 58.0%   
Total revenues Rs m6,87733,254 20.7%   
Gross profit Rs m1,6044,505 35.6%  
Depreciation Rs m2211,777 12.5%   
Interest Rs m38240 15.7%   
Profit before tax Rs m1,5872,905 54.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718511 140.5%   
Profit after tax Rs m8692,394 36.3%  
Gross profit margin %24.213.7 176.2%  
Effective tax rate %45.217.6 257.1%   
Net profit margin %13.17.3 179.7%  
BALANCE SHEET DATA
Current assets Rs m6,23219,455 32.0%   
Current liabilities Rs m1,49010,076 14.8%   
Net working cap to sales %71.528.6 250.2%  
Current ratio x4.21.9 216.6%  
Inventory Days Days8698 88.3%  
Debtors Days Days8367 123.4%  
Net fixed assets Rs m4,04320,260 20.0%   
Share capital Rs m127252 50.4%   
"Free" reserves Rs m8,18326,633 30.7%   
Net worth Rs m8,31026,886 30.9%   
Long term debt Rs m182,340 0.8%   
Total assets Rs m10,38941,173 25.2%  
Interest coverage x43.113.1 329.2%   
Debt to equity ratio x00.1 2.5%  
Sales to assets ratio x0.60.8 80.1%   
Return on assets %8.76.4 136.5%  
Return on equity %10.58.9 117.5%  
Return on capital %19.510.8 181.3%  
Exports to sales %047.6 0.0%   
Imports to sales %014.9 0.0%   
Exports (fob) Rs mNA15,642 0.0%   
Imports (cif) Rs mNA4,884 0.0%   
Fx inflow Rs m5,62215,642 35.9%   
Fx outflow Rs m1,7994,884 36.8%   
Net fx Rs m3,82210,759 35.5%   
CASH FLOW
From Operations Rs m3563,411 10.4%  
From Investments Rs m-279-1,354 20.6%  
From Financial Activity Rs m-225-1,304 17.3%  
Net Cashflow Rs m-148753 -19.7%  

Share Holding

Indian Promoters % 63.4 45.9 138.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.4 -  
FIIs % 0.0 25.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.4 209.8%  
Shareholders   37,287 36,892 101.1%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   DR. DATSONS LABS  STRIDES PHARMA SCIENCE  FDC LTD.  JUBILANT LIFE SCIENCES  BIOCON   

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

IPCA LABS Announces Quarterly Results (4QFY19); Net Profit Up 113.4% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 113.4% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Oct 18, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - SANOFI INDIA COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS